Global Nephrostomy Device Market

Nephrostomy Device Market Size, Share, Growth Analysis, By End Use(Hospitals, Emergency Clinics, Ambulatory Centers (ASCs).), By Product(Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2633 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 77

Nephrostomy Device Market Insights

Nephrostomy Device Market size was valued at USD 1.27 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.67 billion by 2031, at a CAGR of 8.6% during the forecast period (2024-2031)

The nephrostomy devices market is being driven by various factors such as the growing prevalence of kidney stone disorder, a rising demand for minimally invasive surgical procedures, and increased awareness about these devices.

According to a study published in the National Center for Biotechnology Information (NCBI), urolithiasis affects approximately 12% of the global population. Additionally, the American Cancer Society predicts that there will be around 81,800 new cases of kidney cancer in the United States in 2023, further highlighting the high prevalence of kidney diseases.

The increasing incidence of kidney diseases, including cancer, creates a greater demand for nephrostomy devices. Individuals with cancer may require a nephrostomy if there is a blockage in their urinary system. This drives the market growth as the need for these devices increases. The demand for minimally invasive surgeries (MIS) is another significant factor contributing to the market's growth.

Compared to open surgery, minimally invasive surgery offers numerous advantages, such as shorter hospital stays, reduced blood loss, lower postoperative complications, less operative pain, improved cosmetic outcomes, and equivalent oncological results. These benefits drive the demand for nephrostomy devices, as they are commonly used in MIS procedures.

While the market has positive growth prospects, there are some challenges that may hinder its progress. Alternative procedures and the associated risks related to nephrostomy present potential obstacles to market growth. It is important to consider these factors when evaluating the overall market dynamics.

US Nephrostomy Device Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nephrostomy Device Market size was valued at USD 1.27 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.67 billion by 2031, at a CAGR of 8.6% during the forecast period (2024-2031)

The competitive landscape of the nephrostomy devices market encompasses various details about individual competitors operating within the market. These details include company overviews, financial information, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites and facilities, production capacities, strengths and weaknesses of the company, product launches, product range, and dominant applications. It is important to note that these data points specifically pertain to the companies' activities and focus within the nephrostomy devices market. 'Boston Scientific Corporation (United States)', 'Cook Medical Incorporated (United States)', 'Olympus Corporation (Japan)', 'C. R. Bard, Inc. (United States)', 'Medtronic plc (Ireland)', 'Teleflex Incorporated (United States)', 'BD (Becton, Dickinson and Company) (United States)', 'Coloplast Group (Denmark)', 'ROCAMED (France)', 'UROMED Kurt Drews KG (Germany)', 'Argon Medical Devices (United States)', 'Eurovision GmbH (Germany)', 'Amecath (Spain)', 'SURGIMEDIK (Turkey)', 'Envaste Medical (United States)', 'TROGE MEDICAL GmbH (Germany)', 'Porges SA (Argentina)', 'Well Lead Medical Co., Ltd. (China)', 'Surgitech (India)', 'Allium Medical Solutions Ltd. (Israel)', 'Stryker Corporation (United States)', 'Zimmer Biomet (United States)'

Advancements in nephrostomy devices, such as improved catheter materials, better imaging techniques for guidance, and enhanced drainage systems, have increased the effectiveness and safety of nephrostomy procedures. These technological advancements drive market growth as healthcare providers seek to adopt more advanced and efficient devices.

There is a growing preference for disposable nephrostomy devices over reusable ones. Disposable devices offer advantages such as reduced risk of cross-contamination and infection transmission, ease of use, and convenience. Healthcare facilities are increasingly adopting disposable devices to improve patient safety and minimize the need for reprocessing and sterilization

North America has been the leading market in the past and is projected to continue witnessing substantial growth in the future. This can be attributed to favorable reimbursement policies, growing awareness about these products, the presence of highly skilled physicians, and well-established healthcare facilities in the region. Additionally, the region's quick adoption of technologically advanced medical products is expected to drive market growth. Increased government funding for research and development activities related to surgical devices and procedures is also positively impacting the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Nephrostomy Device Market

Report ID: SQMIG35A2633

$5,300
BUY NOW GET FREE SAMPLE